Progress of research on stem cells including their genetic modifications allowed to obtain very promising results. However, one of the main barriers that (ex vivo) therapy has been encountered was delivery of genetic construct to the target cell. As well plasmids (delivered with using physico-chemical methods) as viral vectors have its prominent place at preparations aimed to implant genetically modified stem cells (auto- or allogenic origin) to recipient organ.